Author:
Rubinstein Larry V.,Steinberg Seth M.,Kummar Shivaani,Kinders Robert,Parchment Ralph E.,Murgo Anthony J.,Tomaszewski Joseph E.,Doroshow James H.
Subject
Statistics and Probability,Epidemiology
Reference10 articles.
1. Compressing drug development timelines in oncology using ‘phase 0’ trials;Kummar;Nature Reviews/Cancer,2007
2. Designing phase 0 cancer clinical trials;Murgo;Clinical Cancer Research,2008
3. Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice;Kinders;Molecular Interventions,2007
4. Optimal two-stage designs for phase II clinical trials;Simon;Controlled Clinical Trials,1989
5. Phase 0 pharmacodynamic, pharmacokinetic study of ABT-888, an inhibitor of poly (ADP-ribose) polymerase (PARP), in patients with advanced malignancies;Kummar;Annals of Oncology,2008
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献